Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab

Inflammatory Bowel Disease
Do you want to read an article? Please log in or register.